Comparative analysis of the diagnosis of liver fibrosis by M- and XL-elastometry in patients with chronic hepatitis C


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Accurate diagnosis of the stage of liver fibrosis is one of the key factors determining the tactics of management of patients with chronic hepatitis C. Non-invasive methods for liver fibrosis evaluation are becoming more prevalent in the world medical practice. Transient elastometry using Fibroscan device is one of the instrumental methods for non-invasive diagnosis of liver fibrosis. Elastometry using M probe, or M-elastometry, is the most common method, but operator can face a number of complexities, causing the «difficult elastometry». XL probe was developed to overcome these difficulties. The article discusses the factors that can contribute to false results of M- and XL-elastometry; additional criteria for choosing between M- and XL-probe are examined and proposed.

Texto integral

Acesso é fechado

Sobre autores

M. Galushko

Medical center “Medelite"

I. Bakulin

FSBEI HE “North-Western State Medical University n.a. I.I. Mechnikov" of RMH

Email: igbakulin@yandex.ru
MD, Prof., Head of the Department of Propaedeutics of Internal Diseases, Gastroenterology and Dietology

A. Timokhina

Medical center “Medelite"

Bibliografia

  1. Schuppan D., Ruehl M., Somasundaram R., Hahn E.G. Matrix as modulator of hepatic fibrogenesis. Semin. Liver Dis. 2001;21(3):351-72.
  2. Yang C., Zeisberg M., Mosterman B., Sudhakar A., Yerramalla U., Holthaus K., Xu L., Eng F., Afdhal N., Kalluri R. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology. 2003;124(1):147-59.
  3. Friedman S.L. Liver fibrosis - from bench to bedside. J. Hepatol. 2003;38 (Suppl. 1):S38-S53.
  4. Яковенко Э.П., Яковенко А.В., Иванов А.Н., Агафонова Н.А., Прянишникова А.С. Фиброз печени: механизмы развития и вопросы терапии. Фарматека. 2011;12:1-3.
  5. Friedman S.L. Mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gatroenterol. Hepatol. 2004;1(3):98-105.
  6. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. European Association for the Study of the Liver. J. Hepatol. 2015;63(1):199-236.
  7. de Torres M., Poynard T. Risk factors for liver fibrosis progression in patient with chronic hepatitis C. Ann. Hepatol. 2003;2(1):5-11.
  8. Ryder S.D., Irving W.L., Jones D.A., Neal K.R., Underwood J.C. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut. 2004;53(3):451-55.
  9. Bedossa P., Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology. 1996.24(2):289-93.
  10. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981.1(5):431-35.
  11. Ishak K.G. Chronic hepatitis: morphology and nomenclature. Mod. Pathol. 1994.7(6): 690-713.
  12. Bedossa P. Presentation of a grid for computer analysis for compilation of histopathologic lesions in chronic viral hepatitis C. Cooperative study of the METAVIR group. Ann. Pathol. 1993.13(4):260-65.
  13. Максютова Г.Ф., Давлетшин Р.А., Давлетшина Г.К., Билалов Ф.С. Возможности биопсии печени при диагностике стадии цирроза. Вестник Челябинского государственного университета. 2013;7(298). Биология. Вып. 2:202-03.
  14. Foucher J., Chanteloup E., Vergniol J., Castera L., Le Bail B., Adhoute X., Bertet J., Couzigou P., de Ledinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55(3):403-8.
  15. Friedrich-Rust M., Ong M.F., Martens S., Sarrazin C., Bojunga J., Zeuzem S., Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960-74.
  16. Ferraioli G., Tinelli C., Dal Bello B., Zicchetti M., Filice G., Filice C. Liver Fibrosis Study Group. Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. Hepatology. 2012;56(6): 2125-33.
  17. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 2001;357(262):1069-75.
  18. Бакулин И.Г., Галушко М.Ю. Сравнительная оценка диагностической эффективности неинвазивных методов диагностики фиброза печени. Рос. журнал гастроэнтерол., гепатол, лолопроктол. Приложение № 40. 2012;22(5):70.
  19. Ющук Н.Д., Знойко О.О., Сафиуллина Н.Х., Келли Е.И. Пункционная биопсия печени и возможности неинвазивного мониторинга фиброза при хроническом вирусном гепатите С. Клинические перспективы гастроэнтерологии, гепатологии. 2002.1:9-16.
  20. Poynard T., Ratziu V., Bedossa P. Appropriateness of liver biopsy. Can. J. Gastroenterol. 2000;14(6):543-48.
  21. Bedossa P., Dargere D., Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003:38(6):1449-57.
  22. Regev A., Berho M., Jeffers L.J., Milikowski C., Molina E.G., Pyrsopoulos N.T., Feng Z.Z., Reddy K.R., Schiff E.R. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 2002;97(10):2614-18.
  23. The French METAVIR Cooperative Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 1994;20(1)Pt. 1:15-20.
  24. Кляритская И.Л., Шелихова Е.О., Мошко Ю.А. Транзиентная эластография в оценке фиброза печени. Крымский терапевтический журнал. 2015;3:18-30.
  25. Щербинина М.Б. Эластография печени: новый подход к диагностике и оценке эффективности терапии фиброза и цирроза печени. Здоровье Украины. 2013Гепатология:10-2.
  26. Vezutti F., Arena U., Marra F., Pinzani M. Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut. 2009;58(2):157-60.
  27. Глушенков Д.В., Павлов Ч.С., Ивашкин В.Т., Галушко М.Ю. Вклад эластометрии в клиническую оценку тяжести цирроза печени. Рос. журнал гастроэнтерол., гепатол, колопроктол. Приложение № 32. 2008;18(5):84.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies